News 5 Cleveland (Your Health Matters)
12/11 10:04A
Scripps News Group
Retatrutide, the next generation of GLP-1 drug from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage clinical trial, the company announced . In fact, some of the participants dropped out...